Care Formulation Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.50 M
as on 24-10-2024
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.80 Cr
as on 24-10-2024
- Satisfied Charges ₹ 3.22 Cr
as on 24-10-2024
- Revenue 15.10%
(FY 2023)
- Profit -15.90%
(FY 2023)
- Ebitda -2.60%
(FY 2023)
- Net Worth 39.00%
(FY 2023)
- Total Assets 21.11%
(FY 2023)
About Care Formulation Labs
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹24.80 Cr. The company has closed loans amounting to ₹3.22 Cr, as per Ministry of Corporate Affairs (MCA) records.
Naveen Jindal and Pawan Jindal serve as directors at the Company.
- CIN/LLPIN
U24100DL2010PTC210765
- Company No.
210765
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Nov 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Care Formulation Labs Private Limited offer?
Care Formulation Labs Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Ophthalmic Drops, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Pharmaceutical Medicine.
Who are the key members and board of directors at Care Formulation Labs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naveen Jindal  | Director | 25-Nov-2010 | Current |
| Pawan Jindal | Director | 25-Nov-2010 | Current |
Financial Performance of Care Formulation Labs.
Care Formulation Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.1% increase. The company also saw a substantial fall in profitability, with a 15.9% decrease in profit. The company's net worth Soared by an impressive increase of 39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Care Formulation Labs?
In 2023, Care Formulation Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Jan 2014 | ₹24.80 Cr | Open |
Others Creation Date: 25 Jun 2024 | ₹1.50 M | Satisfied |
Others Creation Date: 29 Jun 2021 | ₹1.99 Cr | Satisfied |
How Many Employees Work at Care Formulation Labs?
Care Formulation Labs has a workforce of 18 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Care Formulation Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Care Formulation Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
